Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.36
- Piotroski Score 3.00
- Grade Buy
- Symbol (ERAS)
- Company Erasca, Inc.
- Price $2.60
- Changes Percentage (-1.52%)
- Change -$0.04
- Day Low $2.51
- Day High $2.67
- Year High $3.45
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $6.50
- High Stock Price Target $7.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.84
- Trailing P/E Ratio -2.83
- Forward P/E Ratio -2.83
- P/E Growth -2.83
- Net Income $-125,042,000
Income Statement
Quarterly
Annual
Latest News of ERAS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Laken Riley's Final Moments Captured on Jogging Trail Cameras: See Video
Video footage of Laken Riley's final moments before her death, a nursing student at Augusta University, was played during the trial of murder suspect Jose Ibarra. Riley was last seen jogging on the Un...
By PEOPLE.com | 2 days ago -
Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
Novo Nordisk A/S shares declined, erasing gains due to competition and supply constraints on obesity drugs. Despite struggles, analysts predict a potential rebound as the company faces stiff competiti...
By Yahoo! Finance | 2 days ago -
Where To Buy Taylor Swift the Eras Tour in Toronto Tickets
Taylor Swift's Eras Tour is hitting Toronto with three magical nights at the Rogers Centre. Fans can still grab tickets for an unforgettable experience filled with hits from her career....
By Newsweek | 3 days ago
